Nu Eyne Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
Nu Eyne General Information
Description
Developer of a medical device designed to focus on treating ophthalmological disorders. The company's device mimics the innate biological signal to induce efficient and proper healing of damaged tissues and nerves and uses tissue engineering and neuromodulation technology to treat dry eye syndrome and eye pain, enabling medical practitioners to cure optical disorders with ease.
Contact Information
Website
www.nueyne.comCorporate Office
- Room 608, Mario Tower, 28
- Digital-ro 30-gil, Guro-gu
- Seoul
- South Korea
Corporate Office
- Room 608, Mario Tower, 28
- Digital-ro 30-gil, Guro-gu
- Seoul
- South Korea
Nu Eyne Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 10. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | 25-Sep-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Jul-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 01-Aug-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 01-Feb-2020 | Completed | Product Development | |||
| 4. Early Stage VC (Series A) | 11-Nov-2018 | Completed | Product Development | |||
| 3. Accelerator/Incubator | 08-Dec-2017 | $137K | $577K | Completed | Product Development | |
| 2. Accelerator/Incubator | 01-Nov-2017 | $441K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nu Eyne Patents
Nu Eyne Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1121835-S1 | Goggle type massaging device | Active | 29-Nov-2024 | ||
| US-20260048262-A1 | Neuromodulation device associated with sleep cycle | Inactive | 14-Aug-2024 | ||
| US-20260041911-A1 | Low frequency electrode treatment device | Pending | 12-Aug-2024 | ||
| US-20240108406-A1 | Renal denervation catheter | Inactive | 05-Apr-2021 | ||
| WO-2022215760-A1 | Renal denervation catheter | Inactive | 05-Apr-2021 | A61B18/1492 |
Nu Eyne Signals
Nu Eyne Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yozma Group Korea | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| COMEUP STARS | Accelerator/Incubator | |||
| Compa Ventures | Venture Capital | Minority | ||
| Open water Investment | Venture Capital | Minority |
Nu Eyne FAQs
-
When was Nu Eyne founded?
Nu Eyne was founded in 2017.
-
Where is Nu Eyne headquartered?
Nu Eyne is headquartered in Seoul, South Korea.
-
What is the size of Nu Eyne?
Nu Eyne has 11 total employees.
-
What industry is Nu Eyne in?
Nu Eyne’s primary industry is Therapeutic Devices.
-
Is Nu Eyne a private or public company?
Nu Eyne is a Private company.
-
What is Nu Eyne’s current revenue?
The current revenue for Nu Eyne is .
-
How much funding has Nu Eyne raised over time?
Nu Eyne has raised $18.9M.
-
Who are Nu Eyne’s investors?
Yozma Group Korea, MedTech Innovator, COMEUP STARS, Compa Ventures, and Open water Investment are 5 of 9 investors who have invested in Nu Eyne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process